Becker, D; Sfakianakis, I; Krupp, M et al.
Genetic Pathways Controlling Liver Development and HepatocarcinogenesisLIVER TRANSPLANTATION. Bd. 16. H. 6. 2010 S. S125-S125
Becker, D; Sfakianakis, I; Krupp, M et al.
GENETIC SIGNATURES SHARED IN EMBRYONIC LIVER DEVELOPMENT AND LIVER CANCER DEFINE PROGNOSTICALLY RELEVANT SUBGROUPS IN HCCHEPATOLOGY. Bd. 52. H. 4. 2010 S. 947A-947A
Bork, K
Hereditary angioedema with normal C1 inhibitorIMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. Bd. 30. 2010 S. 20-28
Hemmerling, J; Wegner-Kops, J; Sommer, M et al.
Human Langerhans cells reconstitute in skin xenograftsONKOLOGIE. Bd. 33. 2010 S. 271-271
Trojandt, S; Grabbe, S; Reske-Kunz, AB et al.
Human monocyte-derived dendritic cells are affected by the antitumour agent topotecanIMMUNOLOGY. Bd. 131. 2010 S. 100-100
Zahn, S; Kirschsiefen, P; Jonuleit, H et al.
Human primary dendritic cell subsets differ in their IL-12 release in response to Leishmania major infectionEXPERIMENTAL DERMATOLOGY. Bd. 19. H. 10. 2010 S. 924-926
Cicardi, M; Banerji, A; Bracho, F et al.
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary AngioedemaNEW ENGLAND JOURNAL OF MEDICINE. Bd. 363. H. 6. 2010 S. 532-541
Bork, K
Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor DeficiencyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 125. H. 2. 2010 S. AB165-AB165
Brosch, S; Haak, S; Lorenz, B et al.
IL-22 contributes to disease progression in Leishmania major-infected miceJOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 130. 2010 S. S126-S126
Dinges, S; Kostka, SL; Becker, C et al.
IL-23 is not required for Th17 induction in murine cutaneous leishmaniasisEXPERIMENTAL DERMATOLOGY. Bd. 19. H. 2. 2010 S. 199-199